In recent years, the osteoarthritis treatment market is anticipated to grow rapidly during the forecast period. According to the World Health Organization, around 10% to 15% of all persons over the age of 60 have osteoarthritis, with women having a higher prevalence than males. According to the United Nations, adults over the age of 60 will make up more than 20% of the global population by 2050. A conservative estimate of 15 percent of this 20 percent will have symptomatic osteoarthritis, with one-third of this group seriously afflicted.
